Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1722 | BEAM Beam Therapeutics Inc. - Common Stock | 28.77 USD | -3.33% | +7.47% | +13.05% | +71.45% | 2.97 B USD | ||
| 1724 | IRON Disc Medicine, Inc. - Common Stock | 80.34 USD | +0.66% | +2.96% | +7.95% | +33.06% | 3.08 B USD | ||
| 1749 | ZLAB Zai Lab Limited - American Depositary Shares | 25.31 USD | -2.69% | -0.35% | +32.24% | -5.17% | 2.84 B USD | ||
| 1785 | NRIX Nurix Therapeutics, Inc. - Common stock | 26.06 USD | -2.47% | -3.12% | +8.72% | +132.47% | 2.70 B USD | ||
| 1791 | VRDN Viridian Therapeutics, Inc. - Common Stock | 24.16 USD | -0.54% | +6.15% | +23.96% | +7.62% | 2.74 B USD | ||
| 1796 | ATAI AtaiBeckley Inc. - Common Stock | 7.35 USD | -0.41% | +1.52% | +2.51% | +86.08% | 2.73 B USD | ||
| 1839 | PGEN Precigen, Inc. - Common Stock | 7.04 USD | -2.22% | +9.66% | +30.61% | +68.42% | 2.52 B USD | ||
| 1846 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.43 USD | -2.95% | -5.01% | -1.75% | +126.66% | 2.48 B USD | ||
| 1851 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.85 USD | +0.08% | -1.19% | -5.55% | -13.80% | 2.55 B USD | ||
| 1854 | NKTR Nektar Therapeutics - Common Stock | 71.62 USD | -3.24% | +0.14% | +0.87% | -2.25% | 2.45 B USD | ||
| 1876 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.54 USD | -0.10% | -1.55% | -1.04% | +10.93% | 2.44 B USD | ||
| 1878 | OCUL Ocular Therapeutix, Inc. - Common Stock | 10.80 USD | -2.53% | -1.64% | +25.00% | -6.09% | 2.37 B USD | ||
| 1879 | NUVB Nuvation Bio Inc. Class A Common Stock | 6.74 USD | -2.74% | +7.67% | +1.97% | +131.62% | 2.37 B USD | ||
| 1886 | KOD Kodiak Sciences Inc - Common Stock | 37.07 USD | -3.29% | -12.18% | -10.48% | +261.66% | 2.33 B USD | ||
| 1899 | PHVS Pharvaris N.V. - Ordinary Shares | 36.16 USD | -0.30% | +2.73% | +4.66% | +56.88% | 2.36 B USD | ||
| 1903 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 33.69 USD | +4.37% | +7.64% | -6.26% | +13.28% | 2.43 B USD | ||
| 1913 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.54 USD | -2.82% | -5.52% | +10.94% | +139.68% | 2.23 B USD | ||
| 1921 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.11 USD | -2.11% | -0.83% | -7.75% | -37.80% | 2.22 B USD | ||
| 1936 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 8.46 USD | -2.08% | +49.21% | +24.41% | +245.31% | 2.20 B USD | ||
| 1939 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 38.00 USD | -0.39% | -0.76% | +6.65% | +22.98% | 2.21 B USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |